Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024)
Historic Current Leases for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q4 2024 value amounting to $268000.0.
- Whitehawk Therapeutics' Current Leases fell 3824.88% to $268000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $268000.0, marking a year-over-year decrease of 3824.88%. This contributed to the annual value of $268000.0 for FY2024, which is 3824.88% down from last year.
- According to the latest figures from Q4 2024, Whitehawk Therapeutics' Current Leases is $268000.0, which was down 3824.88% from $322000.0 recorded in Q3 2024.
- Whitehawk Therapeutics' 5-year Current Leases high stood at $434000.0 for Q4 2023, and its period low was $9955.0 during Q2 2021.
- Its 5-year average for Current Leases is $257931.6, with a median of $322000.0 in 2024.
- As far as peak fluctuations go, Whitehawk Therapeutics' Current Leases plummeted by 9103.58% in 2021, and later soared by 315464.59% in 2022.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Current Leases stood at $94787.0 in 2020, then skyrocketed by 38.2% to $131000.0 in 2021, then soared by 200.76% to $394000.0 in 2022, then rose by 10.15% to $434000.0 in 2023, then plummeted by 38.25% to $268000.0 in 2024.
- Its last three reported values are $268000.0 in Q4 2024, $322000.0 for Q3 2024, and $374000.0 during Q2 2024.